Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations.
Mavragani CP, Kirou KA, Seshan SV, Crow MK.
Rheumatology (Oxford). 2023 Jul 5;62(7):2534-2538. doi: 10.1093/rheumatology/keac641.
Crescentic glomerulonephritis in children.
Mayer U, Schmitz J, Bräsen JH, Pape L.
Pediatr Nephrol. 2020 May;35(5):829-842. doi: 10.1007/s00467-019-04436-y. Epub 2020 Feb 12.
Bullous systemic lupus erythematosus in females.
Sprow G, Afarideh M, Dan J, Hedberg ML, Werth VP.
Int J Womens Dermatol. 2022 Jul 25;8(3):e034. doi: 10.1097/JW9.0000000000000034. eCollection 2022 Oct.
[Long-term outcome of type V lupus membranous glomerulonephritis].
Pastén V R, Massardo V L, Rosenberg G H, Radrigán A F, Roessler B E, Valdivieso D A, Jacobelli G S.
Rev Med Chil. 2005 Jan;133(1):23-32. doi: 10.4067/s0034-98872005000100004. Epub 2005 Mar 10.
Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
Chan TM, Li FK, Wong RW, Wong KL, Chan KW, Cheng IK.
Nephron. 1995;71(3):321-7. doi: 10.1159/000188739.
Rituximab therapy in lupus nephritis: current clinical evidence.
Ramos-Casals M, Diaz-Lagares C, Soto-Cardenas MJ, Brito-Zeron P, Cuadrado MJ, Sanna G, Bertolaccini L, Khamashta MA.
Clin Rev Allergy Immunol. 2011 Jun;40(3):159-69. doi: 10.1007/s12016-010-8205-3.
Immune gene expression and functional networks in distinct lupus nephritis classes.
Gilmore AC, Wilson HR, Cairns TD, Botto M, Lightstone L, Bruce IN, Terence Cook H, Pickering MC; MASTERPLANS Consortium.
Lupus Sci Med. 2022 Jan;9(1):e000615. doi: 10.1136/lupus-2021-000615.
Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathy.
Ye T, Jiang M, Zeng X, Zong D, Du Y, Li X, Huang B, Tang X.
Lupus Sci Med. 2023 Dec 28;10(2):e001051. doi: 10.1136/lupus-2023-001051.
MMP2 and MMP9 associate with crescentic glomerulonephritis.
Phillips TM, Fadia M, Lea-Henry TN, Smiles J, Walters GD, Jiang SH.
Clin Kidney J. 2017 Apr;10(2):215-220. doi: 10.1093/ckj/sfw111. Epub 2016 Dec 26.
Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1).
Shimizu S, Sugiyama N, Masutani K, Sadanaga A, Miyazaki Y, Inoue Y, Akahoshi M, Katafuchi R, Hirakata H, Harada M, Hamano S, Nakashima H, Yoshida H.
J Immunol. 2005 Dec 1;175(11):7185-92. doi: 10.4049/jimmunol.175.11.7185.
